Clinical trials
Diabetes Mellitus, Type 1 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 8 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 11 |
| Oslo University Hospital | 6 |
| Haukeland University Hospital | 3 |
| Boehringer Ingelheim | 2 |
| Eli Lilly and Company | 2 |
| Norwegian University of Science and Technology | 2 |
| St. Olavs Hospital | 2 |
| Grill, Valdemar, M.D. | 1 |
| Helse Stavanger HF | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 38 |
| Diabetes Mellitus | 11 |
| Diabetes Complications | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Enterovirus Infections | 2 |
| Feeding and Eating Disorders | 2 |
| Hypoglycemia | 2 |
| Addison Disease | 1 |
| Autoimmune Diseases | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.